Betty Jean Swartz

Betty Jean (BJ), Swartz joined Esperion as Vice President of Market Access, HEOR & Policy in February 2021 and was named Chief Strategy Officer in March 2022. She is responsible for the oversight of the organization's vision, innovative capabilities, and corporate strategy in addition to driving Global/US Market Access initiatives, developing of the value proposition via Health Economics Outcomes Research, and synthesizing with Government Affairs/Policy initiatives. BJ will be spearheading the organization’s strategic planning processes while creating brand cohesion, and message alignment and also driving key innovation efforts while leveraging the organization’s product data and value proposition to provide insights into shaping corporate branding.

BJ has 30 years of pharma/biotech experience, spending the first half of her career at Wyeth Pharmaceuticals, where she held various commercial leadership roles leading up to the Vice President of Healthcare Systems. Post Wyeth, BJ has led both Global/US Market Access and Government Affairs across various companies, from small pre-IPO, and midsize to large biotech companies including Auxilium, Kaleo, Celgene, Portola, and, most recently, Agios. She also founded her own boutique market access consulting firm.